Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
BioVaxys Enters Major Bioproduction Agreement With Wuxi Biologics (Hong Kong) Ltd. To Synthesize Proteins For Its SARS-CoV-2 Vaccine And COVID-T™ Immunodiagnostic Programs 2021-03-15 20:00
BioVaxys Expanding Technology Platform To Address Emerging SARS-CoV-2 Variants 2021-03-01 21:00
BioVaxys Announces Appointment To Its Scientific Advisory Board 2021-02-22 21:00
BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production 2021-02-18 21:00
BioVaxys and Procare Health Announce Broad Co-Development, Joint Commercialization and Marketing Collaboration for Cancer and Viral Vaccines 2021-02-10 21:26
Covid-T™ Clinical Development Program Initiated Regulatory Advisory Group Engaged 2021-01-28 21:46
BioVaxys Announces Initiation Of Cancer Vaccine EU Clinical Program, Completion Of BVX-0320 Preclinical Program 2021-01-25 21:00
BioVaxys Vaccine Platform Stimulates Robust T-cell Response Against Viral Antigens 2020-12-21 21:00
1 2